Workshop on the TRIPS Agreement and Public Health

WTO OMCPage 1

Workshop on the TRIPS Agreement and Public Health

Geneva, 21 to 24September 2010

Draft Programme

______

Tuesday, 21September 2010

8h30Registration of Participants

9h00 – 9h15Opening of the Workshop

9h15 – 9h30Introduction of Participants

Theme I:Introduction

9h30 – 10h30The Interface Between Intellectual Property Rights and Public Health

Speakers:Mr. Antony TAUBMAN, Director, Intellectual Property Division, World Trade Organization (WTO)

Mr. ZafarMIRZA,Coordinator, Department of Public Health, Innovation and Intellectual Property,Director General's Office, World Health Organization (WHO)

Ms. Konji SEBATI, Consultant, Global Issues Sector, WIPO World Intellectual Property Organization (WIPO)

10h30 – 10h45Discussion

10h45 – 11h00Coffee Break

11h00 – 12h00Overview: The WTO Multilateral System and the TRIPS Agreement

Speaker:Mr. Hannu WAGER, Counsellor, Intellectual Property

Division(WTO)

12h00 – 12h15Discussion

Theme II:The TRIPS Agreement As It Relates to Public Health

12h15 – 13h00TRIPS Provisions of Direct Relevance to Public Health

Speaker:Mr. Wolf MEIER-EWERT, Counsellor, Intellectual

Property Division(WTO)

13h00 – 14h30Lunch Break

14h30 – 15h00TRIPS Provisions of Direct Relevance to Public Health (cont'd)

Speaker:Mr. Wolf MEIER-EWERT(WTO)

15h00 – 15h15Discussion

15h15 – 16h00Group Exercises

Wednesday, 22 September 2010

Theme II: The TRIPS Agreement As It Relates to Public Health (cont'd)

09h00 – 09h30The Doha Declaration on the TRIPS Agreement and Public Health

Speaker:Ms. Jayashree WATAL, Counsellor, Intellectual

Property Division(WTO)

09h30 – 09h45Discussion

09h45 – 10h15Group Exercises

10h15 – 10h30Coffee Break

10h30 – 12h30The Paragraph 6 System

Speaker:Mr. Roger KAMPF, Counsellor, Intellectual Property

Division(WTO)

12h30 – 12h45Discussion

12h45 – 13h00Introduction to Case Study

13h00 – 14h30Lunch Break

Theme III: The TRIPS Agreement and the Wider Action to Address Public Health Problems

14h30 – 15h30Panel:Use of TRIPS flexibilities, Including the Paragraph 6 System

Speakers:Mr. Jose Victor CHAN-GONZAGA, Second Secretary, Permanent Mission of the Philippines, Geneva

Mr. Darren SMITH, Second Secretary, Permanent Mission of Canada, Geneva

15h30 – 16h00Discussion

Thursday, 23 September2010

09h00 – 10h45Case Study

10h45 – 11h00Coffee Break

11h00 – 12h00Group Reporting on Case Study

Theme III: The TRIPS Agreement and the Wider Action to Address Public Health Problems (cont'd)

12h00 – 12h45Procurement of Patented Medicines

Speakers:Mr. Robert ANDERSON, Counsellor, Intellectual Property Division (WTO)

Ms. Carmen Perez CASAS, Senior Global Health Technical Officer, The Global Fund

12h45 – 13h00Discussion

13h00 – 14h30Lunch Break

14h30 – 15h45Competition Rules

Speakers:Mr. Robert ANDERSON(WTO)

Mr. Nuno PIRES DE CARVALHO,Acting Director, Intellectual Property and Competition Policy Division (WIPO)

Mr. Jonathan BERGER, Honorary research fellow, School of Law, University of the Witwatersrand, Johannesburg, South Africa

15h45 – 16h00Discussion

16h30 – 18h00QuakerICTSD-QUNO Dialogue "IPRs in Bilateral and Regional Trade Agreements and Public Health" (Delegate's Lounge, 4th floor)

Friday, 24 September2010

09h00 – 09h20Regulatory Approval, Quality Control and Effectiveness of Medicines

Speaker:Mr.Lembit RÄGO, Coordinator, Quality Assurance and Safety, Department of Essential Medicines and Pharmaceutical Policies (WHO) (WHO)

09h20 – 09h40 Patent Landscaping

Speaker:Mr. Lutz MAILÄNDER, Head, Patent Information Section (WIPO)

09h40 – 10h00Discussion

10h00 – 10h15Coffee Break

10h15 – 10h45The WHO Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property

Speaker:Mr. Peter BEYER(WHO)

10h45 – 12h45Panel:TRIPS, Innovation and Public Health

Speakers:Mr. Andrew JENNER, Director, Intellectual Property & Trade, International Federation of Pharmaceutical Manufacturers Associations (IFPMA)

Ms. Lidia MALLO, Sr. Manager Government Affairs,EuropeanGeneric MedicinesAssociation (EGA)

Ms. KatyATHERSUCH, MSF Campaign for Access to Essential Medicines(MSF)

Dr. Tshinko Ilunga, Co-Chair African Network for Drugs and Diagnostics Innovation (ANDI) Task Force, Health Development Specialist

Ms. Sylvie FONTEILLES-DRABEK, Senior Legal Officer, Medicines for Malaria Venture (MMV)

12h45 – 13h00Discussion

13h00 – 14h30Lunch Break

14h30 – 15h00Roundtable: Experiences and Lessons learned from the Workshop

15h00 – 15h15Closing Remarks